Project Grant HT94252310460
- The U.S. Defense Health Agency awarded a $962,498 Project Grant to Vanderbilt University Medical Center (VUMC) under the Military Medical Research and Development program (CFDA 12.420) to develop and evaluate a novel tele-assessment tool for autistic adults. The 3-year project, running from September 1, 2023 to August 31, 2026, aims to design and test a remote assessment platform to better support the healthcare needs of this population. As a major academic medical center, VUMC has extensive...
- This $749,143 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Vanderbilt University Medical Center's "TRAINING THE FUTURE PEDIATRIC WORKFORCE TO IMPLEMENT BEST PRACTICES FOR ASD WITHIN PRIMARY CARE" initiative. The project aims to train future pediatric healthcare providers on best practices for diagnosing and managing autism spectrum disorder (ASD) within primary care settings. The 3-year...
- Federal Project Grant Award Summary Vanderbilt University's Sponsored Programs Administration received a $158,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded June 1, 2025, with completion scheduled for May 31, 2027. The research project, titled "Metabotropic Glutamate Receptor 7 and Learning in NF1," focuses on advancing biomedical understanding of neurological function relevant to military medical...
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.39 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds biomedical research investigating the molecular basis of post-injury syndrome and mineralization disorders, with particular focus on decoding inflammatory mechanisms underlying these conditions. This research...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $3.64 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with a completion date of August 31, 2029. The project, titled "Empowered Relief for Spine Surgery: Improving Outcomes with Innovative Rehabilitation Strategies," focuses on developing and implementing innovative rehabilitation approaches designed to...
- This Project Grant award, titled "EFFECTIVENESS OF AN INDIVIDUALIZED PROGRESSIVE TREATMENT FOR EXPANDING SOUND TOLERANCE IN ADULTS WITH AUTISM SPECTRUM DISORDER: A CROSSOVER RANDOMIZED CONTROLLED TRIAL (RCT)", is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $1,971,504.00 award, which runs from April 15, 2025 to April 14, 2029, supports a randomized controlled trial to evaluate the effectiveness of an individualized...
- This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.19 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2025, through April 30, 2029. This four-year research initiative addresses toxicant-mediated pulmonary hypertension in Southwest Asia veterans, supporting advanced biomedical research designed to transform healthcare for military service members and...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $700,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, with a completion date of August 14, 2027. The award supports research investigating the DPEP1-neutrophil axis in microsatellite stable colorectal cancer, contributing to the DHA's broader mission of transforming healthcare for service members and the...
- This Project Grant award for $546,681.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the "PROJECT IMPACT-AUTISM: INTERNET-BASED MODEL FOR PARAEDUCATORS TO AUGMENT COMPREHENSIVE TREATMENT FOR AUTISTIC LEARNERS" project at Temple University in Philadelphia, PA. The project aims to develop an internet-based training model for paraeducators to enhance comprehensive treatment approaches for autistic learners. The award has a...
This $3,149,863 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a 4-year evaluation of tele-assessment services for autism spectrum disorder (ASD) in underserved communities. The award was made to Vanderbilt University Medical Center (VUMC), a nonprofit academic medical center in Nashville, Tennessee that has extensive experience supporting federal biomedical research and healthcare initiatives through contracts and grants. The project aims to assess the feasibility and effectiveness of delivering remote diagnostic and treatment services for ASD to individuals in underserved areas, leveraging VUMC's medical and research capabilities. The award commenced on Sep 1, 2023 and is scheduled for completion on Aug 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $3.1m | 8/22/23 |